A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
Clinical trial NCT07758634 · RECRUITING
Trial details
- NCT number
- NCT07758634
- Sponsor
- CRISPR Therapeutics AG
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-08
- Primary completion
- 2028-07-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.